A Study in People With Idiopathic Pulmonary Fibrosis to Test Whether Pirfenidone Influences the Amount of BI 1015550 in the Blood
Clinical trial NCT06241560 · COMPLETED
Trial details
- NCT number
- NCT06241560
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-05
- Primary completion
- 2026-08-05
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.